DUBLIN--(BUSINESS WIRE)--Jul. 10, 2013--
Alkermes
plc (NASDAQ: ALKS) announced today that it will webcast its Research
and Development (R&D) Day presentation on Wednesday, July 17, 2013. The
webcast will begin at 1:00 p.m. EDT (6:00 p.m. BST). At the meeting,
members of Alkermes’ senior management will provide detailed information
on the company’s lead clinical programs, discuss its distinctive R&D
strategy and introduce new product candidates.
A live webcast of the event will be available on the Investors tab of
the company’s website at www.alkermes.com.
To ensure a timely connection to the webcast, it is recommended that
users register at least 15 minutes prior to the scheduled start. This
webcast will be archived on Alkermes’ website for one month.
Alkermes plc is a fully integrated, global biopharmaceutical company
that applies its scientific expertise and proprietary technologies to
develop innovative medicines that improve patient outcomes. The company
has a diversified portfolio of more than 20 commercial drug products and
a substantial clinical pipeline of product candidates that address
central nervous system (CNS) disorders such as addiction, schizophrenia
and depression. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and manufacturing facilities in
Gainesville, Georgia and Wilmington, Ohio. For more information, please
visit Alkermes’ website at www.alkermes.com.
Source: Alkermes plc
Alkermes:
Eva Stroynowski, +1 781-609-6823
Corporate
Communications
